Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

CellaVision

150.60 SEK

+0.53 %

1,475 following

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for CellaVision

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue178.7186.7723.2194.8191.3175.6197.2759.0
EBITDA48.861.3219.066.559.649.865.5241.4
EBIT38.451.3177.757.150.339.555.1202.1
EBIT-%21.5 %27.5 %24.6 %29.3 %26.3 %22.5 %27.9 %26.6 %
Profit before taxes38.951.5176.952.548.039.254.5194.3
Net income31.140.9140.741.537.631.342.6153.1
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.